MOTS‑c 10mg

 59,00

MOTS-C 10 mg – Grail Formula Quality — researched and verified with Liquilabs s.r.o. Czechia. Analytical validation confirms 99.5 percent purity assay content 10.83 mg RT identification 0.999 spectrum 998 endotoxin below 0.001 EU per mg and no detectable heavy metals or microbial contamination. Supplied as a 10 mg lyophilized mitochondrial-derived peptide with full COA traceability. For research use only — not for human or veterinary use.

Availability: In stock: ships within 1 day after payment confirmation.

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of MOTS-C supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF082025020

Key analytical results include:

  • Assay Content: 10.83 mg
  • Identification – Retention Time: 0.999
  • Identification – Spectrum: 998
  • Purity: greater than 99.5 percent
  • Bacterial Endotoxins: below 0.001 EU per mg
  • Total Aerobic Microbial Count: not detected
  • Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

MOTS-C is a mitochondrial-derived peptide research compound frequently studied in controlled laboratory environments focused on cellular metabolic regulation and mitochondrial signalling pathways.

The compound belongs to a class of short peptides encoded within mitochondrial DNA that are investigated for their role in intracellular energy regulation and metabolic signalling systems.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, MOTS-C has become a compound referenced in experimental mitochondrial signalling and metabolic regulation research models.

Compound Overview

MOTS-C is a mitochondrial-derived peptide encoded within the mitochondrial genome and studied in biochemical research examining mitochondrial signalling and metabolic regulation.

The peptide has attracted scientific interest due to its interaction with pathways involved in cellular energy balance and metabolic signalling.

Within experimental laboratory systems, MOTS-C is often examined in models studying mitochondrial communication with nuclear signalling networks and intracellular metabolic control mechanisms.

These experimental systems allow scientists to investigate mitochondrial peptide signalling and its potential influence on cellular metabolic pathways.

Historical Background and Scientific Context

Scientific research into mitochondrial signalling expanded significantly during the early twenty-first century as new mitochondrial-derived peptides were discovered.

Researchers studying mitochondrial DNA identified several short peptides encoded within the mitochondrial genome that appear to participate in cellular regulatory processes.

MOTS-C was identified as one of these mitochondrial-derived peptides and subsequently became a subject of experimental biochemical research exploring mitochondrial-to-nuclear signalling pathways.

Since its discovery, the peptide has been studied in various experimental models investigating metabolic signalling, mitochondrial communication and intracellular regulatory mechanisms.

Mechanistic Focus in Research

Within experimental laboratory environments, MOTS-C is commonly studied in relation to mitochondrial signalling pathways and cellular metabolic regulation.

Research investigations frequently explore the compound in experimental models examining:

<ul
  • Verified and analysed with Liquilabs s.r.o. Czechia
  • 99.5 percent purity with validated assay content
  • No detectable heavy metals or microbial contamination
  • Endotoxin below 0.001 EU per mg
  • Batch GF082025020 – Published September 2025
  • For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.

Related Products

Limited Research Offer

With prices rising everywhere, we want to support our research community.

10%

DISCOUNT